Mayer Brown represented GW Pharmaceuticals plc, a biopharmaceutical company, in a $289.8 million US public offering of American Depositary Shares on the Nasdaq Global Market.
The Mayer Brown team was led by Corporate & Securities partner David Bakst (New York) and included: Corporate & Securities partner Richard Smith (London) and associates George Rudy, Stephanie Grajales (both New York) and Vivian Chiu (London); Tax Transactions & Consulting partners Jason Bazar (New York), Sandy Bhogal and James Hill (both London), senior associate Benjamin Fryer (London) and associate Jared Goldberger (New York); and Intellectual Property partner Richard Assmus and counsel Jonathan Kim (both Chicago).
The Mayer Brown team was led by Corporate & Securities partner David Bakst (New York) and included: Corporate & Securities partner Richard Smith (London) and associates George Rudy, Stephanie Grajales (both New York) and Vivian Chiu (London); Tax Transactions & Consulting partners Jason Bazar (New York), Sandy Bhogal and James Hill (both London), senior associate Benjamin Fryer (London) and associate Jared Goldberger (New York); and Intellectual Property partner Richard Assmus and counsel Jonathan Kim (both Chicago).
Related Capabilities
Industries –
News
-
April 162021
Stay up-to-date on our perspectives
Subscribe to Email